InsiderFlow

ARCH Venture Partners IX, LLC

LYEL

ARCH Venture Partners IX, LLC serves as 10 percent owner at Lyell Immunopharma, Inc. (LYEL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$37.50M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$37.50M

Companies Traded

1

LYEL

Active Period

Mar 2026 – Nov 2026

2 total trades

Most Recent

Buy LYEL

Nov 5, 2026 · $25.00M

ARCH Venture Partners IX, LLC's Insider Trading at Lyell Immunopharma, Inc. (LYEL)

Buys

2 · $37.50M

Sells

0 · $0.00

Total Shares Bought

2,809,352

Total Shares Sold

0

LYEL Price Chart
Loading chart...
DateTypeValue
Nov 5, 2026 Buy$25.00M
Mar 9, 2026 Buy$12.50M